This inventor holds 1 USPTO granted patent. Top assignee: Intron Biotechnology, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Young Jae Hur: Innovator in Bacteriophage Research
Introduction
Young Jae Hur is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of bacteriophage compositions. His work focuses on innovative solutions for preventing and treating infections.
Latest Patents
Young Jae Hur holds 1 patent. His patent involves a composition that includes an isolated bacteriophage Str-PAP-1, which has the ability to specifically kill cells by infecting them. This bacteriophage can be utilized in medical applications to prevent and treat infections. The active ingredient, Str-PAP-1, is characterized by its genome represented by the nucleotide sequence of SEQ. ID. NO: 1.
Career Highlights
Young Jae Hur is currently associated with Intron Biotechnology, Inc., where he continues to advance his research in bacteriophage technology. His work has the potential to revolutionize treatment methods for various infections, showcasing his commitment to innovation in the field.
Collaborations
Some of his notable coworkers include An Sung Kwon and Seong Jun Yoon. Their collaborative efforts contribute to the ongoing research and development at Intron Biotechnology, Inc.
Conclusion
Young Jae Hur's contributions to bacteriophage research highlight the importance of innovation in biotechnology. His work not only addresses critical health challenges but also paves the way for future advancements in infection treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile